Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Revenue

Enzychem Lifesciences had revenue of 16.47B KRW in the quarter ending September 30, 2025, a decrease of -3.18%. This brings the company's revenue in the last twelve months to 72.17B, down -12.06% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.

• Revenue (ttm): 72.17B
• Revenue Growth: -12.06%
• P/S Ratio: 1.42
• Revenue / Employee: 555.16M
• Employees: 130
• Market Cap: 102.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	77.38B	1.34B	1.76%
Dec 31, 2023	76.04B	49.40B	185.46%
Dec 31, 2022	26.64B	3.66B	15.94%
Dec 31, 2021	22.98B	-2.84B	-11.01%
Dec 31, 2020	25.82B	-5.65B	-17.96%